news

according to the nanyueqingfeng.com on august 30, li chuyuan, former party secretary and chairman of guangzhou pharmaceutical group co., ltd. (hereinafter referred to as "guangzhou pharmaceutical group"), is suspected of serious violations of discipline and laws, and is currently undergoing disciplinary review and supervision investigation by the guangdong provincial commission for discipline inspection and supervision.

on the evening of july 22, guangzhou baiyunshan pharmaceutical group co., ltd. issued an announcement stating that the company's board of directors received a written resignation report from the company's chairman, li chuyuan, on the same day. the announcement showed that li chuyuan resigned from the positions of chairman of the company's ninth board of directors, executive director, and director of the board's strategic development and investment committee for personal reasons. after his resignation, li chuyuan no longer holds any position in the company.

at that time, an insider revealed that li chuyuan was under investigation for disciplinary reasons.

on august 22, the listing review department of the national equities exchange and quotations disclosed the "second round review inquiry letter on the application documents for public transfer and listing of guangzhou pharmaceutical co., ltd.", which mentioned the legality and compliance of the controlling shareholder, guangzhou baiyunshan pharmaceutical. the inquiry letter requires the company to explain the impact on the compliance of guangzhou baiyunshan pharmaceutical's operations based on the specific circumstances of li chuyuan's resignation from guangzhou baiyunshan pharmaceutical, and whether it complies with the relevant provisions of article 16 of the "listing rules"; based on li chuyuan's position in the company and his participation in business decision-making, supplement the explanation of whether li chuyuan's related matters have a significant adverse impact on the company's normal operations, and whether the company complies with the relevant provisions of article 16 of the "listing rules".

daily economic news